<SEC-DOCUMENT>0001104659-23-046286-index.html : 20230417
<SEC-HEADER>0001104659-23-046286.hdr.sgml : 20230417
<ACCEPTANCE-DATETIME>20230417171108
ACCESSION NUMBER:		0001104659-23-046286
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20230417
DATE AS OF CHANGE:		20230417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Carisma Therapeutics Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262025616
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271295
		FILM NUMBER:		23824704

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		2674916422

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sesen Bio, Inc.
		DATE OF NAME CHANGE:	20180516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>tm2312583-1_s3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: tm2312583-1_s3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>tm23125832_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
Document 2 - file: tm23125832_ex4-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>tm23125832_ex4-4.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
Document 3 - file: tm23125832_ex4-4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>4
<FILENAME>tm23125832_ex4-5.htm
<DESCRIPTION>EXHIBIT 4.5
<TEXT>
Document 4 - file: tm23125832_ex4-5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>5
<FILENAME>tm23125832_ex4-6.htm
<DESCRIPTION>EXHIBIT 4.6
<TEXT>
Document 5 - file: tm23125832_ex4-6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>tm23125832_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 6 - file: tm23125832_ex5-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>tm23125832_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 7 - file: tm23125832_ex23-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>8
<FILENAME>tm23125832_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
Document 8 - file: tm23125832_ex23-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>tm23125832_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 9 - file: tm23125832_ex-filingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lg_carismatherapeutics-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: lg_carismatherapeutics-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm23125832_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: tm23125832_ex5-1img001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm23125832_ex5-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: tm23125832_ex5-1img002.jpg

</DOCUMENT>
</SEC-DOCUMENT>